Corsi Oscar, Pérez-Cruz Pedro E
Departamento de Medicina Interna, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Proyecto Epistemonikos, Santiago, Chile. Email:
Departamento de Medicina Interna, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Proyecto Epistemonikos, Santiago, Chile; Programa de Medicina Paliativa y Cuidados Continuos, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Medwave. 2017 May 4;17(Suppl2):e6944. doi: 10.5867/medwave.2017.6944.
Pain is one of the most frequent and relevant symptoms in cancer patients. The World Health Organization's analgesic ladder proposes the use of strong opioids associated with adjuvants such as acetaminophen or nonsteroidal anti-inflammatory drugs in step III. However, it is unclear whether adding acetaminophen to an analgesic regimen based on strong opioids has any benefit in cancer patients with moderate to severe pain. To answer this question we searched in Epistemonikos database, which is maintained by screening multiple information sources. We identified two systematic reviews including five randomized trials overall. We extracted data and generated a summary of findings table using the GRADE approach. We concluded that adding acetaminophen to strong opioids might make little or no difference in improving pain management in cancer patients.
疼痛是癌症患者最常见且相关的症状之一。世界卫生组织的镇痛阶梯建议在第三阶段使用与对乙酰氨基酚或非甾体抗炎药等佐剂联合的强效阿片类药物。然而,在基于强效阿片类药物的镇痛方案中添加对乙酰氨基酚对中重度疼痛的癌症患者是否有益尚不清楚。为回答这个问题,我们检索了由筛选多个信息来源维护的Epistemonikos数据库。我们共识别出两项系统评价,其中包括五项随机试验。我们提取了数据,并使用GRADE方法生成了结果总结表。我们得出结论,在强效阿片类药物中添加对乙酰氨基酚对改善癌症患者的疼痛管理可能几乎没有差异或没有差异。